Environmental risk factors for multiple sclerosis. Part II: Noninfectious factors
about
Biomedical and clinical promises of human pluripotent stem cells for neurological disordersBody size and risk of MS in two cohorts of US womenTemporal trends in the incidence of multiple sclerosis: a systematic reviewChronic cerebro-spinal venous insufficiency (CCSVI) and multiple sclerosisPolymorphisms in vitamin D metabolism related genes and risk of multiple sclerosisB Cells and Autoantibodies in Multiple SclerosisRegulatory T cells in autoimmune neuroinflammationReview of the pharmacoeconomics of early treatment of multiple sclerosis using interferon betaBrain innate immunity in the regulation of neuroinflammation: therapeutic strategies by modulating CD200-CD200R interaction involve the cannabinoid systemGender disparities in ocular inflammatory disordersThe gut-brain connection: triggering of brain autoimmune disease by commensal gut bacteriaEpidemiology of environmental exposures and human autoimmune diseases: findings from a National Institute of Environmental Health Sciences Expert Panel WorkshopMigration of engrafted neural stem cells is mediated by CXCL12 signaling through CXCR4 in a viral model of multiple sclerosis.What went wrong? The flawed concept of cerebrospinal venous insufficiency.Two-photon imaging of remyelination of spinal cord axons by engrafted neural precursor cells in a viral model of multiple sclerosis.Clinical, MRI, and CSF markers of disability progression in multiple sclerosis.Correlation of multiple sclerosis (MS) incidence trends with solar and geomagnetic indices: Time to revise the method of reporting MS epidemiological data.An update on immunopathogenesis, diagnosis, and treatment of multiple sclerosisGeomagnetic disturbances may be environmental risk factor for multiple sclerosis: an ecological study of 111 locations in 24 countries.Vitamin D and autoimmune thyroid diseasesThe prevalence of multiple sclerosis in 3 US communitiesNew developments in the treatment of optic neuritis.Smoking is associated with increased lesion volumes and brain atrophy in multiple sclerosisA seasonal periodicity in relapses of multiple sclerosis? A single-center, population-based, preliminary study conducted in Bologna, Italy.A meta-analysis to determine the efficacy and tolerability of anti-B-cell monoclonal antibodies in multiple sclerosisElevated Epstein-Barr virus-encoded nuclear antigen-1 immune responses predict conversion to multiple sclerosisThe pathogenesis of murine coronavirus infection of the central nervous system.Modeling the cumulative genetic risk for multiple sclerosis from genome-wide association data.Smoking and multiple sclerosis: an updated meta-analysisThe human health effects of ozone depletion and interactions with climate change.Multiple sclerosis epidemiology in Latin America: An updated survey.Environmental factors influencing multiple sclerosis in Latin America.The epidemiology of multiple sclerosis in Scotland: inferences from hospital admissions.How implementation of systems biology into clinical trials accelerates understanding of diseases.Genetic factors affecting EBV copy number in lymphoblastoid cell lines derived from the 1000 Genome Project samples.Combined effects of smoking, anti-EBNA antibodies, and HLA-DRB1*1501 on multiple sclerosis risk.Multiple sclerosis-A disease on a dramatically rising trend in Iran: Review of possible reasonsTime of birth, residential solar radiation and age at onset of multiple sclerosisDeficiency of the G protein Gαq ameliorates experimental autoimmune encephalomyelitis with impaired DC-derived IL-6 production and Th17 differentiationCell replacement therapies to promote remyelination in a viral model of demyelination
P2860
Q21284798-94EC5230-03E5-4C4A-8523-FAC9C177701FQ22241653-AB348FC0-514D-4655-863D-F6D485A0C2B9Q22241655-B80F152D-CCDA-4838-8F7A-AF23505AC44AQ22252683-1AD47CDD-6B20-4694-9B62-BA302B0C6702Q24650192-4A4F82E3-7B77-4CD6-BB6D-68EA688DE5D1Q26801386-8FCD8015-B515-4FAB-8C66-26E6B402AF9DQ26825063-984A87F2-2A86-437E-8C91-9B598EF0DFD1Q26864418-6B827718-6404-4D87-990A-6C87418E7494Q26865295-F5B9990B-E8CA-4420-B5AF-FC3CEAB61BF3Q26995402-8F42B376-38E7-49FC-8036-4683CAB11801Q28078888-C083AEE2-2273-484E-A3E4-61B9C77AF1B3Q28390922-3E0459A6-4EC3-457F-A63F-FE8C5DA7C2C3Q30435441-79368271-7A86-485A-9505-930DA387FE68Q30454634-C037673E-4D61-4FC9-83D5-CBDBE71431E1Q30580359-37B343AC-8F5E-478E-9EC4-C2F4E73BAC23Q30712257-01326216-5185-46B1-8A15-4335E363FE3DQ30858141-5CE5036E-1BD7-428E-974A-73012CC5FAC9Q31002774-0A934D1A-6439-45EA-83F8-6C6F171EFC64Q31097992-F9240ABA-50E5-42CC-833C-4139F119D7BBQ33577498-3BEC730B-4BE3-4305-8692-756BFDBB01EEQ33610980-1D1148B9-96EE-4B40-A2F3-BD7A88AFD199Q33702072-51FFB49D-E0CF-4B2E-94CD-24AFC45C00D0Q33707544-08DBF33F-6FF2-4EE2-AD46-877CEA31729FQ33735281-B9BAB453-EAA4-49EE-B1E0-5B3F67DC330EQ33744039-D9A84D6C-BC5B-4074-B48F-6CC306321E02Q33764503-0185F8C2-7694-47C0-9F8C-87667B0BE107Q33779927-77939949-A246-476B-93AB-D3BC75508EA2Q33796163-B0D947D7-DF61-4B90-99A3-0848FD489DD8Q33797795-A8C16AE1-597D-496B-9847-36A5D53E9090Q33799335-A5258146-2B41-4DBB-9CF7-02BA728F64DAQ33803053-CDA858BB-796D-4F8D-9EE6-EB9DB195A14CQ33803071-86DE2FA1-24E4-4E6F-8380-CF73FA026155Q33813291-F6E41443-47E1-4E44-8E4F-3842F2A5B7A6Q33814843-1AEE39C9-F903-4518-AE79-A5EE9FCED85FQ33842180-BF4BBE74-CB6B-44E1-A792-A3AE463F1294Q33874843-2B73CDA6-D804-46CE-A3C7-53ED8E3C4076Q33896817-CC79320C-4DA5-48C8-86CA-F80D86555FCEQ33906598-94F919B0-94D0-4CAD-AEBB-2CFB33D5F630Q33920152-645A25AA-1458-4E50-A4B0-C764D981366BQ34056814-449C6392-3E6F-40F1-AC10-9477EB16F856
P2860
Environmental risk factors for multiple sclerosis. Part II: Noninfectious factors
description
2007 nî lūn-bûn
@nan
2007 թուականին հրատարակուած գիտական յօդուած
@hyw
2007 թվականին հրատարակված գիտական հոդված
@hy
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
name
Environmental risk factors for multiple sclerosis. Part II: Noninfectious factors
@ast
Environmental risk factors for multiple sclerosis. Part II: Noninfectious factors
@en
Environmental risk factors for multiple sclerosis. Part II: Noninfectious factors
@en-gb
Environmental risk factors for multiple sclerosis. Part II: Noninfectious factors
@nl
type
label
Environmental risk factors for multiple sclerosis. Part II: Noninfectious factors
@ast
Environmental risk factors for multiple sclerosis. Part II: Noninfectious factors
@en
Environmental risk factors for multiple sclerosis. Part II: Noninfectious factors
@en-gb
Environmental risk factors for multiple sclerosis. Part II: Noninfectious factors
@nl
prefLabel
Environmental risk factors for multiple sclerosis. Part II: Noninfectious factors
@ast
Environmental risk factors for multiple sclerosis. Part II: Noninfectious factors
@en
Environmental risk factors for multiple sclerosis. Part II: Noninfectious factors
@en-gb
Environmental risk factors for multiple sclerosis. Part II: Noninfectious factors
@nl
P2860
P3181
P356
P1433
P1476
Environmental risk factors for multiple sclerosis. Part II: Noninfectious factors
@en
P2093
Kassandra L. Munger
P2860
P304
P3181
P356
10.1002/ANA.21141
P407
P577
2007-01-01T00:00:00Z